Literature DB >> 30211501

Pembrolizumab plus Chemotherapy in Lung Cancer.

Omer Diker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30211501     DOI： 10.1056/NEJMc1808567

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Are we facing a cure in lung cancer?-KEYNOTE-001 insights.

Authors:  Aharon Y Cohen; Waleed Kian; Laila C Roisman; Dina Levitas; Nir Peled; Yulia Dudnik
Journal:  Ann Transl Med       Date:  2019-09

2.  Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer.

Authors:  Waleed Kian; Laila C Roisman; Nadav Wallach; Dina Levitas; Alexander Yakobson; Yulia Dudnik; Nir Peled; Keren Rouvinov
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.